Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-24 @ 11:25 PM
NCT ID:
NCT00130156
Brief Summary:
The purpose of this study is to investigate the efficacy and safety of Bunazosin with Valsartin compared to Doxazosin with Valsartin for patients with mild to moderate essential hypertension accompanied by metabolic syndrome.
Detailed Description:
This clinical study will comprise a 1 to 2-week washout period, a 5-week mono therapy period with Angiotensinâ…ˇantagonist, and an 8-week alpha blocker add-on treatment period. Total study period will be 15 weeks.
Study:
NCT00130156
Study Brief:
Protocol Section:
NCT00130156